RESUMEN
The cellular and the molecular mechanisms by which long noncoding RNAs (lncRNAs) may regulate presynaptic function and neuronal activity are largely unexplored. Here, we established an integrated screening strategy to discover lncRNAs implicated in neurotransmitter and synaptic vesicle release. With this approach, we identified neuroLNC, a neuron-specific nuclear lncRNA conserved from rodents to humans. NeuroLNC is tuned by synaptic activity and influences several other essential aspects of neuronal development including calcium influx, neuritogenesis, and neuronal migration in vivo. We defined the molecular interactors of neuroLNC in detail using chromatin isolation by RNA purification, RNA interactome analysis, and protein mass spectrometry. We found that the effects of neuroLNC on synaptic vesicle release require interaction with the RNA-binding protein TDP-43 (TAR DNA binding protein-43) and the selective stabilization of mRNAs encoding for presynaptic proteins. These results provide the first proof of an lncRNA that orchestrates neuronal excitability by influencing presynaptic function.
Asunto(s)
Proteínas de Unión al ADN/metabolismo , ARN Largo no Codificante/metabolismo , Vesículas Sinápticas/metabolismo , Animales , Movimiento Celular/genética , Proteínas de Unión al ADN/genética , Células HEK293 , Hipocampo/citología , Humanos , Ratones , Ratones Transgénicos , Neurogénesis/genética , Neuronas/metabolismo , Neurotransmisores/metabolismo , ARN Mensajero/metabolismo , Ratas , Ratas Wistar , TransfecciónRESUMEN
Different isolates of Cydia pomonella granulovirus (CpGV) are used worldwide to control codling moth larvae (Cydia pomonella) in pome fruit production. Two types of dominantly inherited field resistance of C. pomonella to CpGV have been recently identified: Z-chromosomal type I resistance and autosomal type II resistance. In the present study, a CpGV-resistant C. pomonella field population (termed SA-GO) from northeastern Germany was investigated. SA-GO individuals showed cross-resistance to CpGV isolates of genome group A (CpGV-M) and genome group E (CpGV-S), whereas genome group B (CpGV-E2) was still infective. Crossing experiments between individuals of SA-GO and the susceptible C. pomonella strain CpS indicated the presence of a dominant autosomal inheritance factor. By single-pair inbreeding of SA-GO individuals for two generations, the genetically more homogenous strain CpRGO was generated. Resistance testing of CpRGO neonates with different CpGV isolates revealed that isolate CpGV-E2 and isolates CpGV-I07 and -I12 were resistance breaking. When progeny of hybrid crosses and backcrosses between individuals of resistant strain CpRGO and susceptible strain CpS were infected with CpGV-M and CpGV-S, resistance to CpGV-S appeared to be autosomal and dominant for larval survivorship but recessive when success of pupation of the hybrids was considered. Inheritance of resistance to CpGV-M, however, is proposed to be both autosomal and Z linked, since Z linkage of resistance was needed for pupation. Hence, we propose a further type III resistance to CpGV in C. pomonella, which differs from type I and type II resistance in its mode of inheritance and response to CpGV isolates from different genome groups.IMPORTANCE The baculovirus Cydia pomonella granulovirus (CpGV) is registered and applied as a biocontrol agent in nearly all pome fruit-growing countries worldwide to control codling moth caterpillars in an environmentally friendly manner. It is therefore the most widely used commercial baculovirus biocontrol agent. Since 2005, field resistance of codling moth to CpGV products has been observed in more than 40 field plantations in Europe, threatening organic and integrated apple production. Knowledge of the inheritance and mechanism(s) of resistance is indispensable for the understanding of host response to baculovirus infection on the population level and the coevolutionary arms race between virus and host, as well as for the development of appropriate resistance management strategies. Here, we report a codling moth field population with a new type of resistance, which appears to follow a highly complex inheritance in regard to different CpGV isolates.
Asunto(s)
Granulovirus/genética , Granulovirus/aislamiento & purificación , Mariposas Nocturnas/virología , Animales , Europa (Continente) , Ligamiento Genético , Granulovirus/clasificación , Granulovirus/fisiología , Patrón de Herencia , Larva/inmunología , Larva/virología , Malus/parasitología , Mariposas Nocturnas/crecimiento & desarrollo , Mariposas Nocturnas/inmunología , Enfermedades de las Plantas/parasitologíaRESUMEN
Cydia pomonella granulovirus (CpGV) is an important biocontrol agent for the codling moth (CM) in organic and integrated apple production worldwide. Previously, Z chromosome-linked dominant resistance in at least 38 CM field populations in Europe was reported, threatening organic apple production. Growers responded by switching to a different resistance-breaking isolate of CpGV that could control these populations. Here, we report a nonuniform response of different CM field populations to CpGV isolates from CpGV genome groups A to E. Even more strikingly, one field population, NRW-WE, was resistant to all known CpGV genome groups except group B. Single-pair crossing experiments with a susceptible strain, followed by resistance testing of the F1 offspring, clearly indicated cross-resistance to CpGV isolates that had been considered to be resistance breaking. This finding provides clear evidence of a second, broader type of CpGV resistance with a novel mode of inheritance that cannot be fully explained by Z-linkage of resistance. IMPORTANCE: CpGV is registered and used in virtually all commercial apple growing areas worldwide and is therefore the most widely used baculovirus biocontrol agent. Recently, resistance to CpGV products was reported in different countries in Europe, threatening organic growers who rely almost exclusively on CpGV products. This resistance appeared to be targeted against a 24-bp repeat in the pe38 gene in isolate CpGV-M of genome group A, which had been used commercially for many years. On the other hand, resistance could be broken by CpGV isolates from CpGV genome groups B to E. Here, we report clear evidence of a second type of field resistance that is also directed against resistance-breaking isolates of CpGV genome groups C, D, and E and which appears not to be targeted against CpGV pe38 Therefore, we propose to differentiate between type I resistance, which is targeted against pe38 of CpGV genome group A, and a novel type II resistance with an unknown molecular target. This finding stresses the need for further adoption of resistance management strategies for CpGV, since growers cannot rely solely on the use of resistance-breaking CpGV isolates.
Asunto(s)
Granulovirus/fisiología , Mariposas Nocturnas/genética , Mariposas Nocturnas/virología , Control Biológico de Vectores , Animales , Ligamiento Genético , Alemania , Larva/genética , Larva/crecimiento & desarrollo , Larva/virología , Mariposas Nocturnas/crecimiento & desarrolloRESUMEN
We present both the clinical and radiographic data of a 15-year-old boy, suffering from a lytic spondylolisthesis C6-C7 and treated by circumferential fusion.
Asunto(s)
Fusión Vertebral , Espondilolistesis/diagnóstico por imagen , Espondilolistesis/cirugía , Lucha/lesiones , Adolescente , Tornillos Óseos , Humanos , Masculino , Radiografía , Columna Vertebral/cirugía , Espondilolistesis/etiologíaRESUMEN
Insect-specific baculoviruses are increasingly used as biological control agents of lepidopteran pests in agriculture and forestry, and they have been previously regarded as robust to resistance development by the insects. However, in more than a dozen cases of field resistance of the codling moth Cydia pomonella to commercially applied C. pomonella granulovirus (CpGV) in German orchards, resistance ratios exceed 1000. The rapid emergence of resistance is facilitated by sex-linkage and concentration-dependent dominance of the major resistance gene and genetic uniformity of the virus. When the gene is fixed, resistance levels approach 100,000-fold. Our findings highlight the need for development of resistance management strategies for baculoviruses.
Asunto(s)
Granulovirus/fisiología , Patrón de Herencia , Mariposas Nocturnas/genética , Mariposas Nocturnas/virología , Control Biológico de Vectores , Cromosomas Sexuales/genética , Animales , Bioensayo , Cruzamientos Genéticos , Femenino , Genes Dominantes , Genes de Insecto , Genes Virales , Ligamiento Genético , Granulovirus/genética , Masculino , Selección GenéticaAsunto(s)
Vértebras Cervicales , Desplazamiento del Disco Intervertebral/cirugía , Disco Intervertebral , Prótesis e Implantes , Implantación de Prótesis , Osteofitosis Vertebral/cirugía , Fenómenos Biomecánicos , Femenino , Estudios de Seguimiento , Humanos , Persona de Mediana Edad , Oseointegración , Diseño de Prótesis , Falla de Prótesis , Factores de Tiempo , TitanioRESUMEN
Endoprosthetic replacement for spinal cord disorders represents an attractive alternative to fusion in those cases where surgery appears necessary for degenerative disc disease. At least in theory it has been proven that placement of an endoprosthesis minimizes undue stress on the adjoining segments and its possible negative consequences. Furthermore, cervical endoprostheses facilitate speedier rehabilitation and the problems involved in removal of the bone chip become irrelevant. Clinical results reported to date for the cervical spine are very encouraging and indicate that endoprosthetic replacement has been quite successful particularly for difficulties in multilevel approaches. However, long-term results for cervical endoprostheses have not yet been published and therefore at present there are no reference values for the viability of the prosthesis with regard to the aseptic loosening rate. There are also no findings available on how the implanted cervical prosthesis will behave when bone quality diminishes at an advanced age.
Asunto(s)
Vértebras Cervicales , Desplazamiento del Disco Intervertebral/cirugía , Disco Intervertebral , Prótesis e Implantes , Implantación de Prótesis , Osteofitosis Vertebral/cirugía , Fenómenos Biomecánicos , Femenino , Estudios de Seguimiento , Humanos , Persona de Mediana Edad , Oseointegración , Diseño de Prótesis , Falla de Prótesis , Factores de Tiempo , TitanioRESUMEN
Intra-specific recombination between two genotypes of the Cryptophlebia leucotreta granulovirus (CrleGV), namely CV3 and CV4, was studied by mixed infection experiments of larvae of C. leucotreta, followed by in vivo cloning and DNA restriction enzyme analyses of isolated progeny viruses. As a prerequisite for these studies a comparative restriction map for of CV3 and CV4 was constructed for eight restriction enzymes. The mixed infection experiments resulted in the isolation of the recombinant CrleGV CVR, which contained restriction sites typical for both parental viruses. Inter-specific recombination between two different granulovirus species, namely CrleGV CV3 and Cydia pomonella granulovirus (CpGV), was analogously investigated by mixed infections of larvae of C. leucotreta. A survey of more than 300 isolated CrleGV and CpGV clones did not reveal any recombinant, which indicated an extremely low recombination frequency in these experiments. By using a specific PCR approach, however, chimerical fragments from the highly conserved granulin gene sequence could be observed in DNA preparations of virus progeny. Cloning and sequencing indicated recombination between CrleGV and CpGV DNA. Our results suggest that recombination between granulovirus genotypes and granulovirus species result in eventually viable viruses and may contribute to the genetic diversity in this virus group.
Asunto(s)
ADN Viral/genética , Granulovirus/genética , Virus de Insectos/genética , Insectos/virología , Animales , Secuencia de Bases , Cartilla de ADN , ADN Viral/química , Genoma Viral , Genotipo , Geografía , Granulovirus/clasificación , Virus de Insectos/clasificación , Larva/virología , Proteínas de la Matriz de Cuerpos de Oclusión , Reacción en Cadena de la Polimerasa , Recombinación Genética , Mapeo Restrictivo , Alineación de Secuencia , Homología de Secuencia de Ácido Nucleico , Especificidad de la Especie , Proteínas Virales/química , Proteínas Virales/genética , Proteínas Estructurales ViralesAsunto(s)
Vértebras Lumbares/cirugía , Fusión Vertebral , Espondilolistesis/cirugía , Tornillos Óseos , Estudios de Seguimiento , Humanos , Fijadores Internos , Vértebras Lumbares/diagnóstico por imagen , Examen Neurológico , Complicaciones Posoperatorias/diagnóstico por imagen , Sacro/diagnóstico por imagen , Sacro/cirugía , Espondilolistesis/clasificación , Espondilolistesis/diagnóstico por imagen , Espondilolistesis/etiología , Espondilólisis/diagnóstico por imagen , Espondilólisis/etiología , Espondilólisis/cirugía , Cirugía Asistida por Computador , Tomografía Computarizada por Rayos XRESUMEN
SER virus is a member of the family Paramyxoviridae, genus Rubulavirus, which has been isolated from pigs. It is very closely related to SV5 virus serologically, in protein profile, and in nucleotide sequence. However, unlike SV5, SER induces minimal syncytium formation in infected CV-1 or BHK cells. Fluorescence transfer experiments between labeled erythrocytes and infected MDBK cells revealed that SER also induces hemifusion and pore formation with reduced efficiency. The virion polypeptide profiles of SER and SV5 are very similar, except that the SER F1 subunit shows an apparent molecular weight that is about 2 kDa higher than that of SV5. Comparison of the deduced amino acid sequences revealed the SER F (551 aa) to be longer than SV5 F (529 aa) by 22 residues in the cytoplasmic tail (CT) domain. The HN and M gene sequences of the viruses were found to be very similar. The SER F showed minimal fusion activity when coexpressed with either SV5 or SER HN. In contrast, SV5 F was highly fusogenic when coexpressed with either HN protein, indicating that the restricted fusion capacity of SER virus is a property of its F protein. Truncation in the CT of SER F by 22 residues completely rescued its ability to cause syncytium formation, whereas other truncations rescued syncytium formation partially. These results demonstrate that an elongated CT of a paramyxovirus F protein suppresses its membrane fusion activity.
Asunto(s)
Fusión de Membrana/fisiología , Rubulavirus/fisiología , Animales , Secuencia de Bases , Bovinos , Células Cultivadas , Chlorocebus aethiops , Cricetinae , Citoplasma/metabolismo , ADN Viral , Perros , Expresión Génica , Células HeLa , Hemaglutininas Virales/genética , Hemaglutininas Virales/metabolismo , Humanos , Datos de Secuencia Molecular , Fenotipo , Rubulavirus/genética , Rubulavirus/metabolismo , Proteínas Virales de Fusión/genética , Proteínas Virales de Fusión/metabolismo , Proteínas de la Matriz Viral/genéticaRESUMEN
BACKGROUND: Radiation dermatitis is a common side-effect of radiation therapy, but there is no current consensus about its appropriate therapy. OBJECTIVES: To compare treatment with topical 0.1% methylprednisolone vs. 0.5% dexpanthenol in a cohort of patients undergoing fractionated radiation therapy for breast cancer. METHODS: In a randomized, double-blind design, treatment was initiated at the beginning of radiation therapy and continued for 2 weeks after termination of radiation. Outcomes were compared by three different measures: clinical (symptom score), functional (transepidermal water loss, TEWL) and subjective (quality of life, QOL). RESULTS: In a preliminary cohort of untreated patients undergoing radiation therapy, clinical signs and TEWL levels increased progressively during radiation therapy, reaching highest values at 5 and 4 weeks, respectively. Although neither topical treatment reduced the incidence of radiation dermatitis, both delayed the emergence of greatest clinical and TEWL scores until approximately 6 and 5 weeks, respectively. With topical corticosteroids, clinical symptoms and TEWL were less pronounced than with dexpanthenol. Whereas general QOL improved after completion of radiation therapy, skin-related QOL declined. However, the skin-related QOL decline could be at least in part reversed by use of topical corticosteroid vs. dexpanthenol-containing emollient. CONCLUSIONS: We provide evidence that prophylactic and ongoing use of topical therapy with either topical corticosteroid or a dexpanthenol-containing emollient ameliorates, but does not prevent radiation dermatitis. Our data suggest, but do not prove, a benefit of a topical corticosteroid vs. a dexpanthenol-containing emollient. Further controlled studies with larger cohorts will be needed to determine optimal forms of topical therapy for radiation dermatitis.
Asunto(s)
Antiinflamatorios/administración & dosificación , Metilprednisolona/análogos & derivados , Metilprednisolona/administración & dosificación , Ácido Pantoténico/administración & dosificación , Radiodermatitis/tratamiento farmacológico , Enfermedad Aguda , Administración Tópica , Adulto , Anciano , Anciano de 80 o más Años , Neoplasias de la Mama/radioterapia , Estudios de Cohortes , Método Doble Ciego , Femenino , Glucocorticoides , Humanos , Persona de Mediana Edad , Pomadas , Ácido Pantoténico/análogos & derivados , Estudios Prospectivos , Radiodermatitis/etiologíaRESUMEN
While the advantages of C-arm navigation in computer-assisted spine surgery are obvious, the accuracy of pedicle screw placement with virtual fluoroscopy still needs to be verified. The C-arm-based ION system (Medtronic Sofamor Danek) was used to navigate pedicle screw insertion in patients undergoing spinal surgery for various conditions. In a prospective study, a total of 160 screws were inserted in the first 30 consecutive patients since introduction of the system at our institution: 54 at the thoracic spine (highest level: TH4) and 106 at the lumbar spine. Computed tomography (CT) scans were performed postoperatively by two independent radiologists to control the accuracy of screw placement at the level of the pedicles after reconstruction of axial images according to Laine et al. The comparison of the calculated accuracy rate of pedicle screw placement using virtual fluoroscopy with reported results achieved with CT-based navigation shows similar results for virtual fluoroscopy and a remarkable increase of accuracy in comparison to reports on conventional pedicle screw placement.
Asunto(s)
Tornillos Óseos , Fluoroscopía/instrumentación , Enfermedades de la Columna Vertebral/cirugía , Fusión Vertebral/instrumentación , Cirugía Asistida por Computador/instrumentación , Tomografía Computarizada por Rayos X/instrumentación , Interfaz Usuario-Computador , Diseño de Equipo , Humanos , Vértebras Lumbares/diagnóstico por imagen , Vértebras Lumbares/cirugía , Complicaciones Posoperatorias/diagnóstico por imagen , Complicaciones Posoperatorias/cirugía , Estudios Prospectivos , Sensibilidad y Especificidad , Enfermedades de la Columna Vertebral/diagnóstico por imagen , Vértebras Torácicas/diagnóstico por imagen , Vértebras Torácicas/cirugíaRESUMEN
OBJECTIVE: To characterize the epidermal permeability barrier function of skin during exposure to ionizing radiation. DESIGN: A prospective cohort study. SETTING: University hospital medical center. PATIENTS: Fifteen women receiving local radiation therapy (5000-6000 rad [50-60 Gy]) following breast-conserving surgery for breast cancer. MAIN OUTCOME MEASURES: Clinical symptoms and transepidermal water loss (TEWL). RESULTS: Epidermal permeability barrier function is impaired in patients who exhibit clinical signs of radiation dermatitis. The functional damage to the stratum corneum induced by ionizing radiation occurs with a delayed course, starting within a mean period of 11 days and reaching maximal values after a mean period of 27 days (range, 13-75 days). The onset of TEWL increase precedes the onset of radiation dermatitis and the maximal TEWL measurements precede the peak of skin changes. Patients with an early onset of TEWL increase show a longer duration of skin symptoms. CONCLUSIONS: Skin changes caused by radiation dermatitis are associated with an increase in TEWL. The barrier impairment is comparable to the changes observed with UV radiation exposure but exhibits an even more delayed course. Our results suggest that preservation of the epidermal permeability barrier function by topical treatment may ameliorate radiation dermatitis.
Asunto(s)
Fenómenos Fisiológicos de la Piel/efectos de la radiación , Piel/efectos de la radiación , Adulto , Anciano , Femenino , Humanos , Persona de Mediana Edad , Permeabilidad/efectos de la radiación , Estudios Prospectivos , Radiodermatitis/diagnóstico , Radiodermatitis/etiología , Factores de TiempoRESUMEN
PURPOSE: To show that radiotherapy (RT) dose to the noninvolved extended field (EF) can be reduced without loss of efficacy in patients with early-stage Hodgkin's disease (HD). PATIENTS AND METHODS: During 1988 to 1994, pathologically staged patients with stage I or II disease who were without risk factors (large mediastinal mass, extranodal lesions, massive splenic disease, elevated erythrocyte sedimentation rate, or three or more involved areas) were recruited from various centers. All patients received 40 Gy total fractionated dose to the involved field areas but were randomly assigned to receive either 40 Gy (arm A) or 30 Gy (arm B) total fractionated dose for the clinically noninvolved EF. No chemotherapy was given. RT films were prospectively reviewed for protocol violations and recurrences retrospectively related to the applied RT. RESULTS: Of 382 recruited patients, 376 were eligible for randomized comparison, 190 in arm A and 186 in arm B. Complete remission was attained in 98% of patients in each arm. With a median follow-up of 86 months, 7-year relapse-free survival (RFS) rates were 78% (arm A) and 83% (arm B) (P =.093). The upper 95% confidence limit for the possible inferiority of arm B in RFS was 4%. Corresponding overall survival rates were 91% (arm A) and 96% (arm B) (P =.16). The most common causes of death (n = 27) were cardiorespiratory disease/pulmonary embolisms (seven), second malignancy (six), and HD (five). Protocol violation was associated with significantly poorer RFS. Nonirradiated nodes were involved in 42 of 52 reviewed relapses, infield areas in 18, marginal areas in 17, and extranodal sites in 16. CONCLUSION: EF-RT alone attains good survival rates in favorable early-stage HD. The 30-Gy dose is adequate for clinically noninvolved areas. Protocol violation worsens the subsequent prognosis. Relapse patterns suggest that systemic therapy can reduce the 20% long-term relapse rate.
Asunto(s)
Enfermedad de Hodgkin/radioterapia , Radioterapia/métodos , Adolescente , Adulto , Anciano , Fraccionamiento de la Dosis de Radiación , Femenino , Enfermedad de Hodgkin/patología , Humanos , Masculino , Persona de Mediana Edad , Cooperación del Paciente , Pronóstico , Dosificación Radioterapéutica , Análisis de Supervivencia , Resultado del TratamientoRESUMEN
PURPOSE OF THE STUDY: The aim of the study was to evaluate which patient might benefit most from allogeneic stem cell transplantation (SCT) in the treatment of relapsed and/or refractory lymphoma. PATIENTS AND METHODS: Thirty-eight consecutive lymphoma patients receiving either autologous (n = 24) or allogeneic (n = 14) stem cell grafts at our institution from 1986 to 1998 were retrospectively analysed regarding overall survival (OS), disease-free survival (DFS), transplant-related mortality (TRM), and relapse incidence (RI). Uni- and multivariate analyses were performed to identify patient characteristics predictive for outcome after SCT. RESULTS: The probabilities of OS, DFS, TRM, and relapse were 57%, 51%, 29%, and 30% following autologous and 43%, 43%, 29%, and 38% following allogeneic SCT. Disease status (sensitive versus refractory) and the time interval between diagnosis and SCT were the most powerful predictive parameters for OS and TRM, whereas elevated serum LDH levels were signifcant in determining relapse. CONCLUSIONS: In patients with elevated serum LDH levels and bone marrow involvement at the time of transplantation allogeneic was superior to autologous SCT and resulted in better outcome due to a lower relapse incidence strongly suggesting the existence of a graft-versus-lymphoma effect.
Asunto(s)
Trasplante de Células Madre Hematopoyéticas , Enfermedad de Hodgkin/terapia , Trasplante Autólogo , Trasplante Homólogo , Adulto , Anciano , Austria/epidemiología , Biomarcadores de Tumor/sangre , Médula Ósea/patología , Supervivencia sin Enfermedad , Femenino , Supervivencia de Injerto , Enfermedad Injerto contra Huésped/etiología , Enfermedad Injerto contra Huésped/prevención & control , Reacción Injerto-Huésped , Enfermedad de Hodgkin/sangre , Enfermedad de Hodgkin/mortalidad , Humanos , L-Lactato Deshidrogenasa/sangre , Tablas de Vida , Linfoma no Hodgkin/sangre , Linfoma no Hodgkin/mortalidad , Linfoma no Hodgkin/terapia , Masculino , Persona de Mediana Edad , Recurrencia Local de Neoplasia , Pronóstico , Inducción de Remisión , Estudios Retrospectivos , Análisis de Supervivencia , Resultado del TratamientoRESUMEN
This study elucidates the application of an analytic attitude to questions of gender and sexuality. The paper reports on a study group's exploration of the relative heuristic use of two important organising concepts in analytic work with female analysands: primary feminity and the phallic castration complex. A tendency to cling to one position over the other skews analytic listening. Two cases are presented of women struggling to consolidate positive feminine identifications and, to that end, working through conflicting feminine identifications and defences against a resolution of the awareness of gender differences. Analytic listening requires a view of each psychic construction as a layer to be understood in its own right yet as a cloak soon to reveal the next layer--a different construction. The study includes observations on perverse fantasies in women.
Asunto(s)
Angustia de Castración/psicología , Identidad de Género , Terapia Psicoanalítica , Adulto , Fantasía , Femenino , Teoría Freudiana , Humanos , Interpretación PsicoanalíticaRESUMEN
STUDY DESIGN: After posterior stabilization of the spondylolytic lumbosacral level, mobility of the fused vertebrae could be studied before and after an additional anterior endoscopic interbody fusion using roentgen stereophotogrammetric analysis. OBJECTIVE: To determine the in vivo primary lumbosacral stability of additional anterior interbody fusion after transpedicular screw fixation. SUMMARY OF BACKGROUND DATA: In vitro studies indicate a significant decrease in segmental motion after pedicle screw fixation and additional anterior fusion. Roentgen stereophotogrammetric studies demonstrate the adequacy of transpedicular lumbar instrumentation in posterolateral fusions. There are no studies examining the effect of additional anterior interbody fusion after posterior instrumentation in vivo. METHODS: In this study, 15 patients with low-grade spondylolisthesis at L5-S1 underwent a two-stage open posterior and endoscopic anterior lumbar fusion using carbon fiber (Brantigan I/F) cages. At surgery, tantalum markers were implanted into the fifth lumbar (L5) and the first sacral (S1) vertebra. All the patients were examined by roentgen stereophotogrammetric analysis after the first and second surgical procedures. RESULTS: After implantation of the posterior pedicle system only, the mean intervertebral mobility determined by roentgen stereophotogrammetric analysis was 0.23 mm in the transverse (x), 0.54 mm in the vertical (y), and 1.2 mm in the sagittal (z) axes. After additional anterior endoscopic fusion with carbon cages, the remaining translation between the fused segment L5/S1 decreased to 0.17 mm in the x, 0.16 mm in the y, and 0.44 mm in the z axes. CONCLUSION: Anterior endoscopic lumbosacral fusion significantly increases the primary stability of the posterior fusion with a pedicle system in two axes of motion.
Asunto(s)
Laparoscopía , Región Lumbosacra/diagnóstico por imagen , Fotogrametría/métodos , Implantación de Prótesis , Fusión Vertebral/métodos , Espondilolistesis/cirugía , Materiales Biocompatibles , Fenómenos Biomecánicos , Tornillos Óseos , Carbono , Femenino , Humanos , Fijadores Internos , Región Lumbosacra/fisiopatología , Masculino , Persona de Mediana Edad , Implantación de Prótesis/instrumentación , Radiografía , Espondilolistesis/diagnóstico por imagen , Espondilolistesis/fisiopatologíaRESUMEN
BACKGROUND/AIMS: Because of the short life expectancy of patients with esophageal cancer, relief of dysphagia associated with low morbidity and mortality must be the aim of any therapeutic strategy. METHODOLOGY: A total of 39 patients with unresectable esophageal cancer were randomly allocated to either receive combined laser-percutaneous radiotherapy (group 1, n = 21) or to have a self-expanding metal stent placed (group 2, n = 18). Some patients in group 2 required initial laser therapy (group 2a, n = 8). Treatment efficacy was evaluated on the basis of improved dysphagia, restenosis, hospital stay, survival time and costs. RESULTS: Both treatments were able to significantly improve dysphagia. Restenosis occurred in 43% of group 1 and 22% of group 2 patients. In group 1, 2 patients had severe bleeding episodes and 2 patients developed esophago-tracheal fistulas. One group 1 patient died due to uncontrollable bleeding and 1 patient to recurrent aspiration. No treatment-related death was observed in group 2. Hospital stay was 30.0 (mean: 5.4) days in group 1, 18.9 (mean: 4.2) days in group 2a and 7.1 (mean: 3.1) days in group 2b. There was no statistical difference between the 3 groups with regard to survival. Costs were highest in group 1 and lowest in group 2b. CONCLUSIONS: The treatment of unresectable esophageal cancer with self-expanding metal stents appears to be simple, safe, as good as laser combined with radiotherapy and cost efficient.
Asunto(s)
Neoplasias Esofágicas/terapia , Terapia por Láser , Cuidados Paliativos , Stents , Anciano , Anciano de 80 o más Años , Neoplasias Esofágicas/radioterapia , Humanos , Persona de Mediana Edad , Cuidados Paliativos/métodosRESUMEN
We determined the current quality of life (QoL) of patients with Hodgkin's disease treated at the Innsbruck University Hospital between 1969 and 1994 at a mean time of 9.1 +/- 7.0 years after their initial treatment. Further aims of our study were to assess potential differences in objective treatment outcome and QoL between patients treated with chemo-, radio- or combined modality therapy and those enrolled in randomised clinical trials or treated according to standard procedures. The QLQ-C30, a health-related and validated self-report questionnaire developed by the Study Group on Quality of Life of the European Organization for Research and Treatment of Cancer (EORTC) was mailed to a cohort of 194 survivors out of a total of 225 patients with Hodgkin's disease; 126 of them (64.9%) returned the completed questionnaire. The 5- and 10-year overall survival rates for the total group of 225 patients were 94.3% and 84.9%, respectively. Irrespective of stage, higher relapse-free survival rates were observed in patients receiving combined modality treatment (P = 0.025). Five-year relapse-free survival rates were 96.6% for patients enrolled in clinical trials and 82.8% for patients treated outside of randomised studies (P = 0.037 in univariate and P = 0.064 in multivariate analysis). Patients treated with combined modality regimens had reduced QoL scores in comparison with those treated with either radiation or chemotherapy alone, but QoL parameters did not differ between patients enrolled in clinical trials and those treated according to standard procedures. Patients with Hodgkin's disease had an excellent long-term prognosis and very high QoL scores a mean of 9.1 years after treatment of their disease. The improved relapse-free survival rates achieved by combined modality regimens must be carefully weighed against the accompanying reduced QoL, since lower relapse rates did not translate into a survival advantage.